How big is the mutation detection kits in genome editing market?

The global mutation detection kits in genome editing market size was estimated at USD 126.9 million in 2020 and is expected to reach USD 158.6 million in 2021.

What is the mutation detection kits in genome editing market growth?

The global mutation detection kits in genome editing market are expected to grow at a compound annual growth rate of 17.3% from 2021 to 2028 to reach USD 455.1 million by 2028.

Which segment accounted for the largest mutation detection kits in genome editing market share?

Academic & research institutes dominated the market in 2020, owing to ongoing clinical trials, a rise in preference for personalized medicine, and R&D activities in clinical diagnostics. Moreover, the outbreak of COVID-19 has served as a catalyst for mutation detection kits in genome editing market expansion.

Who are the key players in mutation detection kits in genome editing market?

Some key players operating in the mutation detection kits in genome editing market include Thermo Fisher Scientific, Takara Bio Inc., Integrated DNA Technologies, Inc., Lucigen, Promega Corporation, GenScript, Synthego, and New England Biolabs.

What are the factors driving the mutation detection kits in genome editing market?

Key factors that are driving the mutation detection kits in genome editing market growth include technological advancements in gene-editing technologies, increasing demand for synthetic genes and genetically modified organisms, and the growing adoption of personalized medicine.